These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 13336437

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of the central and peripheral effects of atropine, scopolamine and some synthetic atropine-like compounds.
    MEYERS FH, ABREU BE.
    J Pharmacol Exp Ther; 1952 Apr; 104(4):387-95. PubMed ID: 14918058
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The psychotropic action of atropine and scopolamine and their place in psychopharmacology. Experimental study].
    FROMMEL E, FLEURY C, SCHMIDT-GINZKEY J, BEGUIN M.
    Arzneimittelforschung; 1962 Mar; 12():309-14. PubMed ID: 13895508
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of atropine, scopolamine and meperidine on man.
    ORKIN LR, BERGMAN PS, NATHANSON M.
    Anesthesiology; 1956 Jan; 17(1):30-7. PubMed ID: 13283339
    [No Abstract] [Full Text] [Related]

  • 13. Cholinergic neurotransmission in the central nervous system.
    Pepeu G.
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:229-. PubMed ID: 4340733
    [No Abstract] [Full Text] [Related]

  • 14. [Central action of 5-hydroxytryptamine in rat treated with atropine and scopolamine (author's transl)].
    Kleinrok Z, Wielosz M.
    Ann Univ Mariae Curie Sklodowska Med; 1977 Apr; 32():169-78. PubMed ID: 614800
    [No Abstract] [Full Text] [Related]

  • 15. Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action.
    Lish PM, Labudde JA, Peters EL, Robbins SI.
    Arch Int Pharmacodyn Ther; 1965 Aug; 156(2):467-88. PubMed ID: 4380481
    [No Abstract] [Full Text] [Related]

  • 16. Central nervous system and autonomic nervous system effects of amantadine and of some standard anti-Parkinson drugs.
    Bianchi C, Tomasi L.
    Pharmacology; 1973 Aug; 10(4):226-37. PubMed ID: 4148634
    [No Abstract] [Full Text] [Related]

  • 17. A theoretical model study of the comparative effectiveness of atropine and scopolamine action in the central nervous system.
    Weinstein H, Srebrenik S, Maayani S, Sokolovsky M.
    J Theor Biol; 1977 Jan 21; 64(2):295-309. PubMed ID: 839804
    [No Abstract] [Full Text] [Related]

  • 18. [On the problem of the effects on the central nervous system of toxic doses of atropine].
    Higuchi H, Lendle L.
    Arch Toxikol; 1966 Jan 21; 22(2):92-7. PubMed ID: 5982787
    [No Abstract] [Full Text] [Related]

  • 19. Effects of intravenous atropine and scopolamine during cyclopropanesuccinylcholine anesthesia.
    COLON-YORDAN E, JIMENEZ-VELEZ JL.
    Anesthesiology; 1962 Jan 21; 23():333-41. PubMed ID: 13880685
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.